DNTH Dianthus Therapeutics, Inc.

HealthcareBiotechnology
$85.47
▼ 5.47%
32
QScore Signal
Short
Confidence: MEDIUM
Long-Term
22
Short-Term
43

Value

14
P/E-280.32
8
P/B2.64
47
P/S3760.98
0
EV/EBITDA-14.18
5

Growth

24
Revenue Growth-67.3%
0
EPS Growth-64.7%
39
FCF Growth-65.1%
37

Momentum

78
12-Month Return328.4%
100
3-Month Return83.5%
100
1-Month Return-2.3%
49
RSI (14)34.21
50
50/200 MABullish
75

Profitability

25
ROE-1.8%
51
ROA-0.9%
16
Gross Margin100.0%
78
Operating Margin-21911.7%
0
Net Margin-1297.0%
0
FCF Yield-4.0%
0

Risk

16
Beta0.09
35
60-Day Volatility65.8%
0

Generated 5/7/2026, 9:56:11 PM · How is this calculated?

QScore Analysis